Comparison of three different docetaxel and cisplatin plus fluorouracil (DCF) as first-line therapy for advanced gastric cancer: A retrospective analysis of the two institution

Inal, A.Koca, D.Kaplan, M. A.Kucukoner, M.Urakci, Z.Dogan, E.Isikdogan, A.2024-04-242024-04-2420130959-80491879-0852https://hdl.handle.net/11468/22697European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO -- SEP 27-OCT 01, 2013 -- Amsterdam, NETHERLANDS[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keyword]Comparison of three different docetaxel and cisplatin plus fluorouracil (DCF) as first-line therapy for advanced gastric cancer: A retrospective analysis of the two institutionComparison of three different docetaxel and cisplatin plus fluorouracil (DCF) as first-line therapy for advanced gastric cancer: A retrospective analysis of the two institutionConference Object49S622S622WOS:000326843604043Q1